logo-loader

Protomer Technologies developing an insulin injectable alternative for diabetes patients

Published: 23:46 13 Jan 2020 GMT

Protomer Technologies Inc CEO Alborz Mahdavi joined Proactive at the Biotech Showcase 2020 in San Francisco. The California-based, privately-held biotechnology company is developing a glucose responsive insulin that can automatically adjust its activity in the body throughout the day.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

1 hour, 40 minutes ago